AUTL · Autolus Therapeutics plc
$2.15
-0.07 (-3.15%)
At close · Aug 14
Market Cap
$572.25M
Shares
266.16M
Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this stock, matched by the stock's CUSIP. Each row is one fund position with its size, value and weight in that fund.
Funds holding AUTL
14 fund positions| Fund | Ticker | Balance | Value | % of Fund | Side | Reported | Open |
|---|---|---|---|---|---|---|---|
| iShares Biotechnology ETF | — | 1,321,681 | $1,823,920 | 0.02% | Long | 2026-03-31 | |
| Fidelity Nasdaq Composite Index Fund | — | 120,878 | $226,042 | 0.00% | Long | 2026-05-31 | |
| BlackRock Health Sciences Term Trust | BMEZ | 135,975 | $187,646 | 0.02% | Long | 2026-03-31 | |
| State Street(R) SPDR(R) S&P(R) International Small Cap ETF | — | 83,540 | $115,285 | 0.01% | Long | 2026-03-31 | |
| PMC Diversified Equity Fund | APCB | 18,516 | $111,096 | 0.02% | Long | 2024-02-29 | |
| Invesco NASDAQ Future Gen 200 ETF | — | 44,936 | $84,030 | 0.44% | Long | 2026-05-31 | |
| Range Cancer Therapeutics ETF | ABUF | 39,347 | $68,070 | 0.76% | Long | 2025-02-28 | |
| ActivePassive International Equity ETF | — | 22,753 | $42,548 | 0.00% | Long | 2026-05-31 | |
| BlackRock Health Sciences Trust | BME | 23,620 | $32,596 | 0.01% | Long | 2026-03-31 | |
| Invesco Nasdaq Biotechnology ETF | — | 10,575 | $19,775 | 0.03% | Long | 2026-05-31 | |
| ProShares Ultra Nasdaq Biotechnology | — | 7,414 | $13,864 | 0.02% | Long | 2026-05-31 | |
| Defiance Nasdaq Junior Biotechnology ETF | ABUF | 1,305 | $8,548 | 0.12% | Long | 2021-09-30 | |
| ProShares UltraPro Nasdaq Biotechnology | ANEW | 610 | $4,990 | 0.02% | Long | 2020-02-29 | |
| Blackstone Alternative Multi-Strategy Fund | — | 13,800 | $19,044 | 0.00% | Short | 2026-03-31 |
Showing 1–14 of 14 positions
Key facts
CIK
1730463
CUSIP
05280R100
13F (30d)
81 filings
79 filers
Visit website
Investor relations